Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Lemoyneon Nov 10, 2024 3:01pm
68 Views
Post# 36305795

RE:RE:RE:Keith Strachan

RE:RE:RE:Keith Strachan I'm actually feeling like this could be it. Keith leaving certainly is a signal, good or bad. With the positive earnings trend, and some catalysts ripe for the taking, I'm almost certain this is a good sign.

LABS finally taking off, potentially over the next near term months, will allow some of us to eventually make money and some people to finally recoup some of theirs.

I firmly believe this should get to at least 1$ for some of the big LABS insiders to bag a decent profit. HIghly probable it goes higher.

Like you, I believe M&A is a high probability short term, and I also believe LABS is either getting acquired, or a big pharma/mj business is taking a big stake in LABS to eventually acquire it all. But anything is possible, it could also be a smaller player being acquired... I think Keith would've stayed if a smaller fish was getting acquired. But maybe not.

If LABS is acquiring, it will take longer to get where we want it to go, but nonetheless, it seems like current mgmt has proven they can get the work done.

Let's see where this goes this week, glta.

<< Previous
Bullboard Posts
Next >>